Meridian to distribute new inflammatory test in Italy

Mon. October 05, 2009; Posted: 02:00 AM

Oct 05, 2009 (Datamonitor via COMTEX) -- VIVO | Quote | Chart | News | PowerRating -- Meridian Bioscience, a fully integrated life science company, has reported that Meridian Bioscience Europe srl, Milan, Italy has signed an agreement with BUHLMANN Laboratories, for distribution in Italy of a test for inflammatory conditions of the intestine, Quantum Blue calprotectin.

The test, which detects calprotectin, a gastrointestinal inflammatory marker, is a fundamental tool in differentiating between inflammatory bowel disease (IBD) and irritable bowel syndrome. Patients suffering from IBS do not have increased fecal calprotectin values.

Fecal calprotectin concentrations, as measured by the BUHLMANN calprotectin assay, are significantly elevated in patients with IBD and correlate well with endoscopic and histological assessment of disease activity, said Meridian. This test will avoid unnecessary colon endoscopies for ulcerative colitis or Crohn's disease and will minimize discomfort while offering substantial savings for patients and health systems, added Meridian.

Antonio Interno, president of Meridian Bioscience Europe, said: "The BUHLMANN calprotectin test fits very well in Meridian's gastroenteric product range providing another key technology for our lab customers. Preliminary customer interest and sales indicate that the BUHLMANN calprotectin test will contribute to FY2010 revenues in Italy. We are also discussing the extension of the distribution agreement to the French market."

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

For full details on Meridian Bioscience Inc (VIVO) click here. Meridian Bioscience Inc (VIVO) has Short Term PowerRatings of 6. Details on Meridian Bioscience Inc (VIVO) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

Archives

Feedback

Email Article Link

Close X

RELATED SITES

Please call 1-213-955-5858 ext. 1

Tax Relief Bank Levy Wage Garnishment

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.